SCHEMBL6962850

SCHEMBL6962850

CCOC(=O)C1=C(c2ccc(F)cc2)NC(C)=C(C#N)C1C(C)C

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
TSHR P16473 2/20 0.50
ADORA3 P0DMS8 2/20 0.48
NPSR1 Q6W5P4 3/20 0.44
NPC1 O15118 1/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
KDM4E B2RXH2 2/20 0.43
CACNA1C Q13936 2/20 0.43
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6961962 0.85 ALDH1A1 (0.48) ALDH1A1TSHRADORA3NPSR1NPC1
SCHEMBL6962273 0.82 ADORA3 (0.58) ALDH1A1ADORA3CA12CA1CA2
SCHEMBL6953463 0.74 ALDH1A1 (0.52) ALDH1A1TSHRNPSR1NPC1KDM4E
SCHEMBL9263843 0.74 CA12 (0.47) ALDH1A1ADORA3NPSR1NPC1CA12
SCHEMBL9272237 0.70 ADORA3 (0.39) ALDH1A1ADORA3CA12CA1CA2
SCHEMBL10297381 0.70 SMN1; SMN2 (0.45) ALDH1A1TSHRADORA3NPSR1NPC1
SCHEMBL8193038 0.67 CACNA1F (0.57) ALDH1A1TSHRADORA3NPSR1CA12
SCHEMBL26688061 0.66 KDM4E (0.48) ALDH1A1NPSR1NPC1CA12CA1
SCHEMBL5323107 0.66 CA12 (0.72) ALDH1A1CA12CA1CA2CA7
SCHEMBL8260846 0.65 NR3C2 (0.61) NPSR1CACNA1CGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0325130-B1 Substituted pyridines BAYER AG (DE) 2003-11-05 EP disclosed
EP-1123924-A1 Substituted pyridines as HMG-COA reductase inhibitors BAYER AG (DE) 2001-08-16 EP disclosed
EP-1123925-A1 Process for preparation of substituted pyridines BAYER AG (DE) 2001-08-16 EP disclosed
US-5401746-A FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND HMG-COA REDUCTASE BAYER AKTIENGESELLSCHAFT (DE) 1995-03-28 US disclosed
US-5169857-A Anticholesterol agents BAYER AKTIENGESELLSCHAFT (DE) 1992-12-08 US disclosed
US-5006530-A Certain 7-[2,6-diisopropyl-4-phenyl-5-lower alkoxymethyl-pyrid-3-yl]-3,5-dihydroxy-6-enoates and derivatives useful for treating circulatory diseases BAYER AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
EP-0325130-A2 Substituted pyridines BAYER AG (DE) 1989-07-26 EP disclosed